Recent Quarter Total Invested
$2.76 B
Recent Quarter Institutional Ownership Percentage
99.41%
Total Invested of Last Quarter
$2.05 B
Ownership Percentage of Last Quarter
96.29%
Protagonist Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 10.22 M | $460.09 M | 100.00% | 16.55% |
| FARALLON CAPITAL MANAGEMENT LLC | 11/14/2024 | 5.86 M | $263.75 M | 0.35% | 9.49% |
| RTW INVESTMENTS, LP | 11/14/2024 | 5.43 M | $244.18 M | 2.64% | 8.78% |
| STATE STREET CORP | 11/14/2024 | 3.18 M | $143.26 M | 52.88% | 5.15% |
| JOHNSON & JOHNSON | 11/13/2024 | 2.45 M | $110.21 M | 0.00% | 3.97% |
| BVF INC/IL | 11/14/2024 | 1.85 M | $83.26 M | -44.26% | 3.00% |
| JEFFERIES FINANCIAL GROUP INC. | 11/14/2024 | 1.81 M | $81.66 M | -11.07% | 2.94% |
| PACER ADVISORS, INC. | 11/12/2024 | 1.73 M | $78.03 M | 405,061.22% | 2.81% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.37 M | $61.87 M | 0.26% | 2.23% |
| PERCEPTIVE ADVISORS LLC | 11/14/2024 | 1.37 M | $61.86 M | 8.34% | 2.23% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 1.31 M | $58.93 M | 8.26% | 2.12% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2024 | 1.20 M | $54.04 M | -40.00% | 1.94% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2024 | 981,295 | $44.16 M | -38.82% | 1.59% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 821,856 | $36.98 M | 39.12% | 1.33% |
| INVESCO LTD. | 11/12/2024 | 653,152 | $29.39 M | 638.58% | 1.06% |
| MORGAN STANLEY | 11/14/2024 | 628,623 | $28.29 M | 82.06% | 1.02% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2024 | 574,775 | $25.86 M | 2,004.55% | 0.93% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 565,503 | $25.45 M | 7.58% | 0.92% |
| JPMORGAN CHASE & CO | 11/08/2024 | 502,985 | $22.63 M | 33.56% | 0.81% |
| WOODLINE PARTNERS LP | 11/14/2024 | 466,518 | $20.99 M | -43.26% | 0.76% |
| KYNAM CAPITAL MANAGEMENT, LP | 11/14/2024 | 456,369 | $20.54 M | -42.95% | 0.74% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 11/14/2024 | 445,352 | $20.04 M | -20.02% | 0.72% |
| EVERSEPT PARTNERS, LP | 11/14/2024 | 445,204 | $20.03 M | -11.99% | 0.72% |
| MANGROVE PARTNERS | 11/14/2024 | 439,314 | $19.77 M | 0.00% | 0.71% |
| COLONY GROUP, LLC | 11/14/2024 | 426,661 | $19.20 M | 100.00% | 0.69% |
| 683 CAPITAL MANAGEMENT, LLC | 11/14/2024 | 420,000 | $18.90 M | -30.52% | 0.68% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 356,333 | $16.04 M | 74.42% | 0.58% |
| POLAR CAPITAL HOLDINGS PLC | 11/14/2024 | 350,000 | $15.75 M | 100.00% | 0.57% |
| COWEN AND COMPANY, LLC | 11/12/2024 | 340,974 | $15.34 M | -71.16% | 0.55% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 322,989 | $14.53 M | -28.72% | 0.52% |
| MARSHALL WACE, LLP | 11/14/2024 | 315,373 | $14.19 M | -44.88% | 0.51% |
| EAGLE ASSET MANAGEMENT INC | 11/12/2024 | 294,280 | $13.60 M | -17.71% | 0.48% |
| KENNEDY CAPITAL MANAGEMENT LLC | 11/14/2024 | 267,033 | $12.02 M | -7.95% | 0.43% |
| CHECKPOINT CAPITAL L.P. | 11/14/2024 | 240,000 | $10.80 M | -32.39% | 0.39% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 232,074 | $10.44 M | -37.95% | 0.38% |
| SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) | 11/07/2024 | 230,114 | $10.36 M | 1,116.63% | 0.37% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 225,589 | $10.15 M | -63.39% | 0.37% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2024 | 214,872 | $9.67 M | -76.38% | 0.35% |
| TD ASSET MANAGEMENT INC | 11/01/2024 | 172,202 | $7.67 M | 16.12% | 0.28% |
| RHUMBLINE ADVISERS | 11/12/2024 | 164,178 | $7.39 M | 93.21% | 0.27% |
| CANDRIAM S.C.A. | 11/13/2024 | 162,492 | $7.31 M | -40.66% | 0.26% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 11/14/2024 | 158,067 | $7.11 M | 100.00% | 0.26% |
| LEGAL & GENERAL GROUP PLC | 11/14/2024 | 157,414 | $7.08 M | 164.40% | 0.25% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 11/14/2024 | 146,657 | $6.60 M | 100.00% | 0.24% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 144,167 | $6.49 M | -51.54% | 0.23% |
| AMERIPRISE FINANCIAL INC | 11/14/2024 | 143,807 | $6.47 M | 100.00% | 0.23% |
| FIRST TRUST ADVISORS LP | 11/13/2024 | 140,924 | $6.34 M | 6.91% | 0.23% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2024 | 137,171 | $6.17 M | 447.48% | 0.22% |
| VICTORY CAPITAL MANAGEMENT INC | 11/05/2024 | 130,797 | $5.89 M | 1,729.33% | 0.21% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 11/14/2024 | 128,654 | $5.79 M | -0.28% | 0.21% |
Protagonist Therapeutics, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of PTGX shares?
During the previous two years, 271 institutional investors and hedge funds held shares of Protagonist Therapeutics, Inc.. The most heavily invested institutionals were:
BlackRock Funding, Inc. /DE: 10.22 M
FARALLON CAPITAL MANAGEMENT LLC: 5.86 M
RTW INVESTMENTS, LP: 5.43 M
STATE STREET CORP: 3.18 M
JOHNSON & JOHNSON: 2.45 M
BVF INC/IL: 1.85 M
-
What percentage of Protagonist Therapeutics, Inc. stock is owned by institutional investors?
99.41% of Protagonist Therapeutics, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at PTGX ?
Institutional investors have bought a total of 65.77 M shares in the last 24 months. This purchase volume represents approximately $3.05 B in transactions.